159 related articles for article (PubMed ID: 19334634)
21. Proarrhythmia as a pharmacogenomic entity: a critical review and formulation of a unifying hypothesis.
Roden DM
Cardiovasc Res; 2005 Aug; 67(3):419-25. PubMed ID: 15936006
[TBL] [Abstract][Full Text] [Related]
22. Influence of channel blockers on cardiac alternans.
Xia H; Zhao X; Bains J; Wortham DC
Annu Int Conf IEEE Eng Med Biol Soc; 2009; 2009():2823-6. PubMed ID: 19964269
[TBL] [Abstract][Full Text] [Related]
23. Potassium channels in cardiac arrhythmias: focus on antiarrhythmic drug action.
Rials SJ; Friehling TD; Marinchak RA; Kowey PR
Prog Clin Biol Res; 1990; 334():111-21. PubMed ID: 2408066
[No Abstract] [Full Text] [Related]
24. Development of a reentrant arrhythmia model in human pluripotent stem cell-derived cardiac cell sheets.
Kadota S; Minami I; Morone N; Heuser JE; Agladze K; Nakatsuji N
Eur Heart J; 2013 Apr; 34(15):1147-56. PubMed ID: 23201623
[TBL] [Abstract][Full Text] [Related]
25. Effect of lidocaine and quinidine on focal ventricular arrhythmias induced by subepicardial epinephrine in cats.
Bhattacharyya TK; Debnath PK
Indian J Exp Biol; 1994 Nov; 32(11):786-8. PubMed ID: 7896307
[TBL] [Abstract][Full Text] [Related]
26. Antiarrhythmic effect of newly synthesized compound 44Bu on model of aconitine-induced arrhythmia -- compared to lidocaine.
Bartosova L; Novak F; Bebarova M; Frydrych M; Brunclik V; Opatrilova R; Kolevska J; Mokry P; Kollar P; Strnadova V; Suchy P
Eur J Pharmacol; 2007 Dec; 575(1-3):127-33. PubMed ID: 17706639
[TBL] [Abstract][Full Text] [Related]
27. [Experimental approaches to determining molecular mechanisms of antiarrhythmic and cardioprotective actions of new compounds].
Dukhanin AS; Khankoeva AI
Vestn Ross Akad Med Nauk; 1999; (3):7-15. PubMed ID: 10222824
[TBL] [Abstract][Full Text] [Related]
28. On the antiarrhythmic effect of Lidocain.
Deli L; Szabó I
Ther Hung; 1969; 17(2):88-9. PubMed ID: 5807613
[No Abstract] [Full Text] [Related]
29. [The cardiotoxic properties of anti-arrhythmia agents].
Spasov AA; Gurova NA
Eksp Klin Farmakol; 1997; 60(2):20-3. PubMed ID: 9206561
[TBL] [Abstract][Full Text] [Related]
30. Lidocaine, tetrodotoxin and their effect on consolidation of spatial memory.
Cimadevilla JM; López F; Nieto L; Aguirre MJ; Fernández R
Psicothema; 2009 Aug; 21(3):471-4. PubMed ID: 19622331
[TBL] [Abstract][Full Text] [Related]
31. [Heart arrhythmias caused by Lidocain therapy].
Du Mesnil de Rochemont ; Grosser KD; Chriske HW
Med Welt; 1970 Oct; 43():1843-5. PubMed ID: 5475551
[No Abstract] [Full Text] [Related]
32. Effect of experimental arrhythmias and antiarrhythmic drugs on succinate dehydrogenase and lactate dehydrogenase activity in cat heart.
Pande M; Bhatnagar M; Kar K; Dhawan BN; Pandey VC
Indian J Exp Biol; 1984 Mar; 22(3):149-52. PubMed ID: 6519687
[No Abstract] [Full Text] [Related]
33. [ANTIARRHYTHMIC EFFECTS OF 2-ETHYL-6-METHYL-3-HYDROXYPYRIDINE HEMISUCCINATE IN COMPARISON TO MEXIDOL.].
Turilova AI; Gan'shina TS; Avdyunina NI; Pyatin BM; Mirzoyan RS
Eksp Klin Farmakol; 2016; 79(7):8-11. PubMed ID: 29782738
[TBL] [Abstract][Full Text] [Related]
34. In silico risk assessment for drug-induction of cardiac arrhythmia.
Suzuki S; Murakami S; Tsujimae K; Findlay I; Kurachi Y
Prog Biophys Mol Biol; 2008 Sep; 98(1):52-60. PubMed ID: 18635251
[TBL] [Abstract][Full Text] [Related]
35. Protection against in vivo focal myocardial ischemia/reperfusion injury-induced arrhythmias and apoptosis by hesperidin.
Gandhi C; Upaganalawar A; Balaraman R
Free Radic Res; 2009 Sep; 43(9):817-27. PubMed ID: 19579067
[TBL] [Abstract][Full Text] [Related]
36. [The antiarrhythmic activity of the trimecain ammonium derivative in myocardial ischemia].
Kostin IaV; Blinov DS; Moiseeva IIa
Eksp Klin Farmakol; 2003; 66(3):29-31. PubMed ID: 12924229
[TBL] [Abstract][Full Text] [Related]
37. [Effect of lidocaine on the leading cycle and focal source of arrhythmia in isolated specimens of rabbit cardiac tissue during hypothermia].
Pertsov AM; Fast VG; Grenader AK
Kardiologiia; 1986 Apr; 26(4):83-6. PubMed ID: 3712960
[No Abstract] [Full Text] [Related]
38. Arrhythmia exacerbation after sodium channel blockade in myotonic dystrophy type 1.
Otten RF; Scherschel JA; Lopshire JC; Bhakta D; Pascuzzi RM; Groh WJ
Muscle Nerve; 2009 Nov; 40(5):901-2. PubMed ID: 19623641
[No Abstract] [Full Text] [Related]
39. [Energy balance of the myocardium and its correction using antiarrhythmics].
Shlygin VV
Biofizika; 1983; 28(2):311-4. PubMed ID: 6849995
[TBL] [Abstract][Full Text] [Related]
40. Dose-related shortening of ventricular tachycardia cycle length after administration of the KATP channel opener bimakalim in a 4-day-old chronic infarct anesthetized pig model.
Aidonidis I; Poyatzi A; Stamatiou G; Lymberi M; Stamatoyannis N; Molyvdas PA
J Cardiovasc Pharmacol Ther; 2009 Sep; 14(3):222-30. PubMed ID: 19587223
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
